肺结核合并糖尿病的治疗方法及临床预后评价

Treatment of Pulmonary Tuberculosis Complicated With Diabetes Mellitus and Clinical Prognosis Evaluation

目的分析肺结核合并糖尿病的治疗方法及临床预后。方法本次对象为肺结核合并糖尿病患者30例和单纯肺结核患者30例,将其分别设为研究组、参照组,时间在2017年3月—2018年3月,患者进入医院后均接受对症治疗,最后对两组患者的治疗效果和临床预后进行总结。结果对比治疗总有效率,研究组(76.7%)低于参照组(96.7%),两组相比较,差异有统计学意义(P <0.05)。对比患者的空洞闭合率,研究组为43.3%,参照组为60.0%,差异无统计学意义(P> 0.05)。结论糖尿病合并肺疾病的临床治疗效果明显低于单纯肺疾病的临床疗效,因此在对此类患者治疗期间需控制其血糖,让其保持在正常水平。

Objective To analyze the treatment and clinical prognosis of pulmonary tuberculosis complicated with diabetes mellitus.Methods The subjects of this study were 30 patients with tuberculosis combined with diabetes and 30 patients with simple tuberculosis.They were divided into study group and reference group.The patients were treated with symptomatic treatment from March 2017 to March 2018.The treatment effect and clinical prognosis of the two groups of patients were summarized.Results Compared with the total effective rate of treatment,the study group(76.7%)was lower than the reference group(96.7%),and the difference was statistically significant(P<0.05).Comparing the patient's cavity closure rate,the study group was 43.3%and the reference group was 60.0%,the difference was not statistically significant(P>0.05).Conclusion The clinical treatment effect of diabetes mellitus complicated with lung disease is significantly lower than that of simple lung disease.Therefore,it is necessary to control the blood sugar during the treatment of such patients to keep it at a normal level.